-
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Consensus Rating of "Moderate Buy" from Analysts
来源: Buzz FX / 20 2月 2025 04:31:12 America/New_York
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeatFebruary 20, 2025 ShareLink copied to clipboard. Shares of Sarepta Therapeutics, Inc.
Read more...